speb/financial-data huggingface dataset:
Financial ratios for AED.BR — annual report dated 2023-12-31
Total revenue: 356974444.4444444
Gross profit: 335245555.5555555
Operating income: 295344444.4444444
Net income: 27261111.111111112
Capital expenditures: 289721111.1111111
Operating cash flow: 255031111.1111111
Depreciation & amortization: 4053333.333333333
Net tangible assets: 3840668888.888889
Owner earnings: -258406666.66666666
Return on net tangible assets (%): -6.728168299387664
Capex to operating income (%): 98.09600842707198
Buffett classification: The Gruesome
Stock price: 60.94444444444444
P/E ratio: 186.60331940696963
Shares outstanding: 83469689
Book value: 3978778888.888889
P/B ratio: 1.2785364470143128
Market cap (USD): 5087013824.055555
Debt to equity: 0.6585108049622148
Current ratio: 0.31263073644514716
Quick ratio: 0.31263073644514716
Interest coverage ratio: 3.659832849137397
COGS to revenue (%): 6.086959228329448
SG&A to revenue (%): 3.5530087743598204
Free cash flow (dilution-adjusted): -34690000
Buyback yield (%): 0
Retained earnings: 179382222.2222222
Receivables turnover: 13.794632889652211
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.607155937001853
FCF margin (%): -9.717782474313443
Revenue growth (%): 21.110485508065853
Rule of 40 score: 11.39270303375241
Financial ratios for AED.BR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 62.05555555555556
Shares outstanding: 83469689
Market cap (USD): 5179757922.944445
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AED.BR — annual report dated 2024-12-31
Total revenue: 362219791.6666667
Gross profit: 339751041.6666667
Operating income: 302350000
Net income: 213636458.33333334
Capital expenditures: 149897916.6666667
Operating cash flow: 258851041.6666667
Depreciation & amortization: 3025000
Net tangible assets: 3702671875
Owner earnings: 66763541.66666666
Return on net tangible assets (%): 1.8031179623948357
Capex to operating income (%): 49.577614243977735
Buffett classification: The Good
Stock price: 51.979166666666664
P/E ratio: 20.30872871603337
Shares outstanding: 83469689
Book value: 3800101041.6666665
P/B ratio: 1.1417288194639563
Market cap (USD): 4338684876.145833
Debt to equity: 0.7112102556483559
Current ratio: 0.31870871388362343
Quick ratio: 0.31870871388362343
Effective tax rate (%): 0.152868722767216
Interest coverage ratio: 3.4805381682135406
COGS to revenue (%): 6.203070764470237
SG&A to revenue (%): 2.646873589067411
Free cash flow (dilution-adjusted): 108953125
Buyback yield (%): 0
Retained earnings: 355135416.6666667
Receivables turnover: 17.808614155484992
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.88518660269687
FCF margin (%): 30.079285424652962
Revenue growth (%): 1.4693901212972114
Rule of 40 score: 31.548675545950175
Financial ratios for AED.BR — quarterly report dated 2024-12-31
Total revenue: 92171875
Gross profit: 87478125
Operating income: 77241666.66666667
Net income: 35330208.333333336
Capital expenditures: 0
Net tangible assets: 3702671875
Owner earnings: 35330208.333333336
Return on net tangible assets (%): 0.9541814539894474
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 51.979166666666664
P/E ratio: 30.700957345136654
Shares outstanding: 83469689
Book value: 3800101041.6666665
P/B ratio: 1.1417288194639563
Market cap (USD): 4338684876.145833
Debt to equity: 0.7112102556483559
Current ratio: 0.31870871388362343
Quick ratio: 0.31870871388362343
Effective tax rate (%): 20.863762570288618
Interest coverage ratio: 1.4907921190188984
COGS to revenue (%): 5.092388540430582
Buyback yield (%): 0
Retained earnings: 355135416.6666667
Receivables turnover: 4.531650107548908
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2480236651892755
Rule of 40 score: 0
Financial ratios for AED.BR — quarterly report dated 2025-03-31
Total revenue: 104165217.39130434
Gross profit: 97965217.39130434
Operating income: 86770652.17391305
Net income: 68439130.43478261
Capital expenditures: 0
Net tangible assets: 3930276086.9565215
Owner earnings: 68439130.43478261
Return on net tangible assets (%): 1.741331370127223
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 60.27173913043478
P/E ratio: 18.377145095014612
Shares outstanding: 83469689
Book value: 4031944565.217391
P/B ratio: 1.2477511134717876
Market cap (USD): 5030863320.706522
Debt to equity: 0.6460487158397246
Current ratio: 0.3856300695339297
Quick ratio: 0.3856300695339297
Effective tax rate (%): -0.6489977301064611
Interest coverage ratio: 6.287233204694023
COGS to revenue (%): 5.952082811586944
SG&A to revenue (%): 1.8407212622088653
Buyback yield (%): 0
Retained earnings: 431178260.8695652
Receivables turnover: 4.182611731843576
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.34979667407827
Revenue growth (%): 13.011932752050823
Rule of 40 score: 13.011932752050823
Financial ratios for AED.BR — quarterly report dated 2025-06-30
Total revenue: 105975294.11764707
Gross profit: 98174117.64705883
Operating income: 90155294.11764707
Net income: 59343529.41176471
Capital expenditures: 0
Net tangible assets: 4069130588.2352943
Owner earnings: 59343529.41176471
Return on net tangible assets (%): 1.458383507851511
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 73.31764705882352
P/E ratio: 37.5188129943424
Shares outstanding: 83469689
Book value: 4179158823.529412
P/B ratio: 1.464361958142435
Market cap (USD): 6119801198.211764
Debt to equity: 0.7268392034985932
Current ratio: 0.3456694915109647
Quick ratio: 0.3456694915109647
Effective tax rate (%): 25.177999288002844
Interest coverage ratio: 6.222655298416565
COGS to revenue (%): 7.3613161780215135
Buyback yield (%): 0
Retained earnings: 293637647.0588235
Receivables turnover: 3.9747164982570715
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3098763948588823
Revenue growth (%): 1.73769783395453
Rule of 40 score: 1.73769783395453
Financial ratios for AED.BR — annual report dated 2025-12-31
Total revenue: 435518823.5294118
Gross profit: 410067058.8235294
Operating income: 367144705.88235295
Net income: 288376470.5882353
Capital expenditures: 114658823.52941176
Operating cash flow: 373936470.5882353
Depreciation & amortization: 3488235.294117647
Net tangible assets: 4239249411.764706
Owner earnings: 177205882.3529412
Return on net tangible assets (%): 4.18012400641401
Capex to operating income (%): 31.22987249778097
Buffett classification: The Good
Stock price: 74.91764705882353
P/E ratio: 21.684684218015665
Shares outstanding: 83469689
Book value: 4316829411.764706
P/B ratio: 1.4485985208425032
Market cap (USD): 6253352700.611765
Debt to equity: 0.7004953254090353
Current ratio: 0.21631621636468806
Quick ratio: 0.21631621636468806
Effective tax rate (%): 13.599785691374432
Interest coverage ratio: 4.664140848017457
COGS to revenue (%): 5.844010254166092
SG&A to revenue (%): 1.9778978959510092
Free cash flow (dilution-adjusted): 259277647.05882353
Buyback yield (%): 0
Retained earnings: 447354117.64705884
Receivables turnover: 21.191310321140307
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.327109583908381
FCF margin (%): 59.53305185701435
Revenue growth (%): 20.236064828340094
Rule of 40 score: 79.76911668535445
Financial ratios for AED.BR — quarterly report dated 2025-12-31
Total revenue: 106217647.05882353
Gross profit: 100963529.41176471
Operating income: 89728235.29411764
Net income: 59415294.11764706
Capital expenditures: 0
Net tangible assets: 4239249411.764706
Owner earnings: 59415294.11764706
Return on net tangible assets (%): 1.4015522170683934
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 74.91764705882353
P/E ratio: 28.101399104041587
Shares outstanding: 83469689
Book value: 4316829411.764706
P/B ratio: 1.4485985208425032
Market cap (USD): 6253352700.611765
Debt to equity: 0.7004953254090353
Current ratio: 0.21631621636468806
Quick ratio: 0.21631621636468806
Effective tax rate (%): 20.284433500647157
Interest coverage ratio: 2.6315989234697397
COGS to revenue (%): 4.946558121504126
Buyback yield (%): 0
Retained earnings: 447354117.64705884
Receivables turnover: 5.1682981281126565
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.3019175668997585
Revenue growth (%): 0.2286881515114403
Rule of 40 score: 0.2286881515114403
Financial ratios for ALFUM.PA — annual report dated 2022-12-31
Total revenue: 7812305.319148936
Gross profit: 4161482.9787234045
Operating income: -803453.1914893617
Net income: -881800
Capital expenditures: 0
Depreciation & amortization: 680723.4042553192
Net tangible assets: 5567764.893617022
Owner earnings: -201076.59574468085
Return on net tangible assets (%): -3.611441926637355
Buffett classification: The Gruesome
Stock price: 9.702127659574467
Shares outstanding: 2983525
Book value: 7824276.5957446825
P/B ratio: 3.6995804112133257
Market cap (USD): 28946540.425531913
Debt to equity: 0.2601378415787198
Current ratio: 2.5209762579084156
Quick ratio: 2.510887930014204
Interest coverage ratio: -3.8527455261493255
COGS to revenue (%): 46.73169047140171
Buyback yield (%): 0
Retained earnings: -2925534.0425531915
Inventory turnover: 65.67735206307893
Receivables turnover: 0.9974692343958645
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.389376278516521
Rule of 40 score: 0
Financial ratios for ALFUM.PA — annual report dated 2023-12-31
Total revenue: 9223673.333333334
Gross profit: 3761298.888888889
Operating income: -2839288.888888889
Net income: -2920823.3333333335
Capital expenditures: 1477326.6666666667
Operating cash flow: -958250
Depreciation & amortization: 1520801.111111111
Net tangible assets: 2873122.222222222
Owner earnings: -2877348.888888889
Return on net tangible assets (%): -100.14711057656982
Buffett classification: The Gruesome
Stock price: 8.377777777777778
Shares outstanding: 2983525
Book value: 5250031.111111108
P/B ratio: 4.760983109518084
Market cap (USD): 24995309.444444444
Debt to equity: 0.9465097349687668
Current ratio: 2.4654038872753965
Quick ratio: 2.4574769815410673
Interest coverage ratio: -28.593360113685954
COGS to revenue (%): 59.22124783738847
Free cash flow (dilution-adjusted): -2608793.3333333335
Buyback yield (%): 0
Retained earnings: -5977548.888888889
Inventory turnover: 99.96618406604578
Receivables turnover: 0.8942733389358465
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.652740665107554
FCF margin (%): -28.283670063481576
Revenue growth (%): 18.065960769927393
Rule of 40 score: -10.217709293554183
Financial ratios for ALFUM.PA — annual report dated 2024-12-31
Total revenue: 10136582.291666668
Gross profit: 4093540.625
Operating income: -1920194.7916666667
Net income: -2631889.5833333335
Capital expenditures: 4170876.041666667
Operating cash flow: -2919236.4583333335
Depreciation & amortization: 936604.1666666667
Net tangible assets: 1030415.625
Owner earnings: -5866161.458333334
Return on net tangible assets (%): -569.3005148610139
Buffett classification: The Gruesome
Stock price: 6.614583333333333
Shares outstanding: 2983525
Book value: 3331081.25
P/B ratio: 5.924435118351836
Market cap (USD): 19734774.739583332
Debt to equity: 2.7007543846811504
Current ratio: 1.3171607237569924
Quick ratio: 1.3132219645711076
Interest coverage ratio: -5.378194729717113
COGS to revenue (%): 59.61616541735847
Free cash flow (dilution-adjusted): -8101682.291666667
Buyback yield (%): 0
Retained earnings: -5497076.041666667
Inventory turnover: 129.3811191150561
Receivables turnover: 1.0071556754251534
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.054410718646153
FCF margin (%): -79.92518640456456
Revenue growth (%): 9.897455442553262
Rule of 40 score: -70.02773096201129
Financial ratios for ALFUM.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1030415.625
Buffett classification: The Gruesome
Stock price: 6.614583333333333
Shares outstanding: 2983525
Book value: 3331081.25
P/B ratio: 5.924435118351836
Market cap (USD): 19734774.739583332
Debt to equity: 2.7007543846811504
Current ratio: 1.3171607237569924
Quick ratio: 1.3132219645711076
Buyback yield (%): 0
Retained earnings: -5497076.041666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALFUM.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 333345.8823529412
Buffett classification: The Gruesome
Stock price: 7.411764705882353
Shares outstanding: 2983525
Book value: 2819051.7647058815
P/B ratio: 7.844192707268278
Market cap (USD): 22113185.29411765
Debt to equity: 4.42892395190039
Current ratio: 1.0349280180394675
Quick ratio: 1.0317714168188379
Buyback yield (%): 0
Retained earnings: -912228.2352941177
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALKS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.26
Shares outstanding: 166675807
Market cap (USD): 3876879270.82
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALKS — annual report dated 2022-12-31
Total revenue: 1182760638.2978723
Gross profit: 950773404.2553192
Operating income: -6477659.574468086
Net income: -168369148.93617022
Capital expenditures: 40696808.5106383
Operating cash flow: 22387234.042553194
Depreciation & amortization: 82831914.89361702
Net tangible assets: 981963829.7872341
Owner earnings: -126234042.5531915
Return on net tangible assets (%): -12.85526398467682
Buffett classification: The Gruesome
Stock price: 26.13
Shares outstanding: 166675807
Book value: 1110375531.9148936
P/B ratio: 3.9223116069562436
Market cap (USD): 4355238836.91
Debt to equity: 0.3635294940469632
Current ratio: 2.270867236439762
Quick ratio: 1.9063852357245321
Interest coverage ratio: -0.4669478527607362
COGS to revenue (%): 19.614047553730682
R&D to revenue (%): 24.528082964935084
SG&A to revenue (%): 53.134885477988306
Free cash flow (dilution-adjusted): -118579787.23404257
Buyback yield (%): 0
Retained earnings: -1807750000
Inventory turnover: 1.2020196452391714
Receivables turnover: 3.744728793921104
Capitalized R&D asset: 290108510.6382979
ROCI (R&D-adjusted, %): 10.104577238138068
FCF margin (%): -10.025679194455813
Rule of 40 score: -10.025679194455813
Financial ratios for ALKS — annual report dated 2023-12-31
Total revenue: 1848227777.7777777
Gross profit: 1567075555.5555556
Operating income: 460135555.5555555
Net income: 395285555.5555555
Capital expenditures: 52993333.33333333
Operating cash flow: 445947777.7777778
Depreciation & amortization: 83252222.22222222
Net tangible assets: 1241853333.3333333
Owner earnings: 425544444.4444444
Return on net tangible assets (%): 34.266884262589606
Capex to operating income (%): 11.516895987172862
Buffett classification: The Great
Stock price: 27.74
P/E ratio: 11.696827321913554
Shares outstanding: 166675807
Book value: 1336317777.777778
P/B ratio: 3.459945652948483
Market cap (USD): 4623586886.179999
Debt to equity: 0.30946148870112394
Current ratio: 2.85553419707047
Quick ratio: 2.4972127176963594
Effective tax rate (%): -23.16336867377271
Interest coverage ratio: 17.980288294546718
COGS to revenue (%): 15.211989864164169
R&D to revenue (%): 16.280220391305786
SG&A to revenue (%): 41.4662093717405
Free cash flow (dilution-adjusted): 280444444.4444444
Buyback yield (%): 0
Retained earnings: -1492808888.8888888
Inventory turnover: 1.3574509404203727
Receivables turnover: 4.992466602437699
Capitalized R&D asset: 495268257.68321514
ROCI (R&D-adjusted, %): 24.62122716491945
Rosenberg metric: 2.1243849411526945
FCF margin (%): 15.173694920960317
Revenue growth (%): 56.26388957596598
Rule of 40 score: 71.4375844969263
Financial ratios for ALKS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 27.99
Shares outstanding: 166675807
Market cap (USD): 4665255837.929999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALKS — quarterly report dated 2024-12-31
Capital expenditures: 10180208.333333334
Buffett classification: The Gruesome
Stock price: 28.76
Shares outstanding: 166675807
Market cap (USD): 4793596209.320001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALKS — annual report dated 2024-12-31
Total revenue: 1622533333.3333335
Gross profit: 1366980208.3333335
Operating income: 438162500
Net income: 382364583.3333334
Capital expenditures: 34398958.333333336
Operating cash flow: 457420833.3333334
Depreciation & amortization: 29721875
Net tangible assets: 1438604166.6666667
Owner earnings: 377687500.00000006
Return on net tangible assets (%): 26.253747121776026
Capex to operating income (%): 7.850730798124745
Buffett classification: The Great
Stock price: 28.76
P/E ratio: 12.536716051290488
Shares outstanding: 166675807
Book value: 1526017708.3333333
P/B ratio: 3.1412454672989405
Market cap (USD): 4793596209.320001
Debt to equity: 0.05156258425900202
Current ratio: 3.0424721463287754
Quick ratio: 2.6493350157674453
Effective tax rate (%): 16.137915492957745
Interest coverage ratio: 18.63034812649482
COGS to revenue (%): 15.75025423206508
R&D to revenue (%): 15.749933231982908
SG&A to revenue (%): 41.424290204618295
Free cash flow (dilution-adjusted): 321878125
Buyback yield (%): 4.352203945082148
Retained earnings: -1017143750
Inventory turnover: 1.3414348750868021
Receivables turnover: 3.998870398800569
Capitalized R&D asset: 552883747.3995272
ROCI (R&D-adjusted, %): 18.6251749745845
Rosenberg metric: -0.6649993445492342
FCF margin (%): 19.8379976785274
Revenue growth (%): -12.211397705309276
Rule of 40 score: 7.626599973218125
Financial ratios for ALKS — quarterly report dated 2025-03-31
Total revenue: 333163043.4782609
Gross profit: 279688043.4782609
Operating income: 14991304.347826086
Net income: 24417391.304347824
Capital expenditures: 9127173.913043479
Operating cash flow: 107403260.86956522
Depreciation & amortization: 8066304.347826087
Net tangible assets: 1551830434.7826085
Owner earnings: 23356521.73913043
Return on net tangible assets (%): 1.505094964992253
Capex to operating income (%): 60.88312064965198
Buffett classification: The Good
Stock price: 33.02
P/E ratio: 56.34954076932871
Shares outstanding: 166675807
Book value: 1643025000
P/B ratio: 3.3496965336133053
Market cap (USD): 5503635147.14
Debt to equity: 0.04902277943057047
Current ratio: 3.333220652198409
Quick ratio: 2.9198206116332006
Effective tax rate (%): 11.867864569029777
COGS to revenue (%): 16.05069981403543
R&D to revenue (%): 23.430556914945676
SG&A to revenue (%): 56.019053211966984
Free cash flow (dilution-adjusted): 71620652.17391305
Buyback yield (%): 0
Retained earnings: -1036950000
Inventory turnover: 0.2681941582442024
Receivables turnover: 0.9526281110917726
Capitalized R&D asset: 78061956.52173913
ROCI (R&D-adjusted, %): 3.6062977759896704
FCF margin (%): 21.497177906104206
Rule of 40 score: 21.497177906104206
Financial ratios for ALKS — quarterly report dated 2025-06-30
Total revenue: 459596470.5882353
Gross profit: 401408235.2941176
Operating income: 109385882.35294119
Net income: 102468235.29411764
Capital expenditures: 15312941.176470589
Operating cash flow: 176708235.29411766
Depreciation & amortization: 9197647.05882353
Net tangible assets: 1812592941.1764705
Owner earnings: 96352941.17647058
Return on net tangible assets (%): 5.315751760234282
Capex to operating income (%): 13.999010518617307
Buffett classification: The Great
Stock price: 28.61
P/E ratio: 37.58183622610309
Shares outstanding: 166675807
Book value: 1911275294.117647
P/B ratio: 2.494980630444163
Market cap (USD): 4768594838.2699995
Debt to equity: 0.04473637558907389
Current ratio: 3.232037188563568
Quick ratio: 2.852712259023405
Effective tax rate (%): 16.922137754080065
COGS to revenue (%): 12.660722833585472
R&D to revenue (%): 19.80509756640736
SG&A to revenue (%): 43.73376133027182
Free cash flow (dilution-adjusted): 132023529.4117647
Buyback yield (%): 0
Retained earnings: -1019877647.0588236
Inventory turnover: 0.2577061753610804
Receivables turnover: 1.0963348581371202
Capitalized R&D asset: 143325040.28132993
ROCI (R&D-adjusted, %): 6.552266074806551
Rosenberg metric: 1.5592767237644043
FCF margin (%): 28.725966768802298
Revenue growth (%): 37.94941533430442
Rule of 40 score: 66.67538210310671
Financial ratios for ALKS — quarterly report dated 2025-09-30
Total revenue: 463747058.8235294
Gross profit: 403051764.7058824
Operating income: 104802352.94117647
Net income: 97365882.35294119
Capital expenditures: 20369411.76470588
Operating cash flow: 119614117.64705883
Depreciation & amortization: 9505882.352941176
Net tangible assets: 1940671764.7058823
Owner earnings: 86502352.94117647
Return on net tangible assets (%): 4.457340726770779
Capex to operating income (%): 19.436025235176576
Buffett classification: The Great
Stock price: 30
P/E ratio: 22.297616784748218
Shares outstanding: 166675807
Book value: 2039331764.7058823
P/B ratio: 2.451917974572986
Market cap (USD): 5000274210
Debt to equity: 0.041304187300107535
Current ratio: 3.6716080613879756
Quick ratio: 3.2689666076397677
Effective tax rate (%): 17.851009975681176
COGS to revenue (%): 13.08801704783287
R&D to revenue (%): 20.73620254449053
SG&A to revenue (%): 43.57674695891523
Free cash flow (dilution-adjusted): 70227058.82352942
Buyback yield (%): 0
Retained earnings: -922511764.7058824
Inventory turnover: 0.2701141902752399
Receivables turnover: 1.1100332008864835
Capitalized R&D asset: 182909739.769821
ROCI (R&D-adjusted, %): 4.758077665060028
Rosenberg metric: 0.01805609409331821
FCF margin (%): 15.143397135862605
Revenue growth (%): 0.9030940185379983
Rule of 40 score: 16.046491154400602
Financial ratios for ALKS — annual report dated 2025-12-31
Total revenue: 1736351764.7058823
Gross profit: 1505225882.3529413
Operating income: 298771764.7058824
Net income: 284310588.2352941
Capital expenditures: 46275294.11764706
Operating cash flow: 612651764.7058823
Depreciation & amortization: 31958823.529411767
Net tangible assets: 2041709411.764706
Owner earnings: 269994117.64705884
Return on net tangible assets (%): 13.223924819629227
Capex to operating income (%): 15.488509820598843
Buffett classification: The Great
Stock price: 27.98
P/E ratio: 16.40314948805366
Shares outstanding: 166675807
Book value: 2140347058.8235295
P/B ratio: 2.1788938670644398
Market cap (USD): 4663589079.86
Debt to equity: 0.038475893134428445
Current ratio: 3.5499257503629673
Quick ratio: 3.188108281180707
Effective tax rate (%): 17.082175330245324
Interest coverage ratio: 20.685509489288915
COGS to revenue (%): 13.31100569889945
R&D to revenue (%): 21.950282505781225
SG&A to revenue (%): 47.5318433036407
Free cash flow (dilution-adjusted): 448962352.9411765
Buyback yield (%): 0
Retained earnings: -864463529.4117647
Inventory turnover: 0.9991455816910363
Receivables turnover: 4.418528553252002
Capitalized R&D asset: 651646755.1470588
ROCI (R&D-adjusted, %): 12.503645648961948
Rosenberg metric: 0.540977503643411
FCF margin (%): 25.856647372211782
Revenue growth (%): 7.014859358156923
Rule of 40 score: 32.87150673036871
Financial ratios for ALKS — quarterly report dated 2025-12-31
Total revenue: 452408235.2941176
Gross profit: 398044705.88235295
Operating income: 68357647.05882353
Net income: 58048235.29411765
Capital expenditures: 1261176.4705882354
Operating cash flow: 200081176.47058824
Depreciation & amortization: 4524705.882352942
Net tangible assets: 2041709411.764706
Owner earnings: 61311764.705882356
Return on net tangible assets (%): 3.0029623389397466
Capex to operating income (%): 1.8449676442241503
Buffett classification: The Great
Stock price: 27.98
P/E ratio: 16.519990453140267
Shares outstanding: 166675807
Book value: 2140347058.8235295
P/B ratio: 2.1788938670644398
Market cap (USD): 4663589079.86
Debt to equity: 0.038475893134428445
Current ratio: 3.5499257503629673
Quick ratio: 3.188108281180707
Effective tax rate (%): 18.278483528495947
Interest coverage ratio: 4.732752301050745
COGS to revenue (%): 12.01647652952695
R&D to revenue (%): 24.1941817255108
SG&A to revenue (%): 48.67961523558889
Free cash flow (dilution-adjusted): 169192941.17647058
Buyback yield (%): 0
Retained earnings: -864463529.4117647
Inventory turnover: 0.23501080737444371
Receivables turnover: 1.151252151785046
Capitalized R&D asset: 203923800
ROCI (R&D-adjusted, %): 3.169411779366671
Rosenberg metric: -0.052068168193885524
FCF margin (%): 37.39828941585814
Revenue growth (%): -2.4450448393520867
Rule of 40 score: 34.95324457650605
Financial ratios for AMPG — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 236696
Buffett classification: The Gruesome
Stock price: 3.94
Shares outstanding: 25338799
Market cap (USD): 99834868.06
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMPG — annual report dated 2022-12-31
Total revenue: 19394492
Gross profit: 8924864
Operating income: 271093
Net income: -677107
Capital expenditures: 735761
Operating cash flow: -3425246
Depreciation & amortization: 957255
Net tangible assets: 20924521
Owner earnings: -455613
Return on net tangible assets (%): -2.1774118509092752
Capex to operating income (%): 271.40538486792354
Buffett classification: The Gruesome
Stock price: 2.12
Shares outstanding: 25338799
Book value: 28755512
P/B ratio: 1.8681028485947322
Market cap (USD): 53718253.88
Debt to equity: 0.16247604980916355
Current ratio: 5.519118173961477
Quick ratio: 3.867799296708353
Interest coverage ratio: 20.8324752170906
COGS to revenue (%): 53.98248121167597
R&D to revenue (%): 5.280504382378255
SG&A to revenue (%): 39.33923095278804
Free cash flow (dilution-adjusted): -4560133
Buyback yield (%): 0
Retained earnings: -7304284
Inventory turnover: 1.5786243948202996
Receivables turnover: 10.76413902115088
Capitalized R&D asset: 1024127
ROCI (R&D-adjusted, %): 2.831448519704319
FCF margin (%): -23.512515821502312
Rule of 40 score: -23.512515821502312
Financial ratios for AMPG — annual report dated 2023-12-31
Total revenue: 15584577
Gross profit: 7275628
Operating income: -2577536
Net income: -2465439
Capital expenditures: 973349
Operating cash flow: -3470890
Depreciation & amortization: 1076225
Net tangible assets: 18998715
Owner earnings: -2362563
Return on net tangible assets (%): -12.435383129859046
Buffett classification: The Gruesome
Stock price: 1.88
Shares outstanding: 25338799
Book value: 26679731
P/B ratio: 1.7855105855452589
Market cap (USD): 47636942.12
Debt to equity: 0.1440599232428543
Current ratio: 11.43713610007323
Quick ratio: 7.076954371867876
COGS to revenue (%): 53.31520387110924
R&D to revenue (%): 15.026683111129676
SG&A to revenue (%): 48.19713104821517
Free cash flow (dilution-adjusted): -4833897
Buyback yield (%): 0
Retained earnings: -9769723
Inventory turnover: 1.2709521783143543
Receivables turnover: 6.12912089856885
Capitalized R&D asset: 3028010.09
ROCI (R&D-adjusted, %): -4.122149225872061
Rosenberg metric: -1.6103823061007083
FCF margin (%): -31.01718448951165
Revenue growth (%): -19.644314478564326
Rule of 40 score: -50.661498968075975
Financial ratios for AMPG — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 92567
Buffett classification: The Gruesome
Stock price: 0.78
Shares outstanding: 25338799
Market cap (USD): 19764263.220000003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMPG — annual report dated 2024-12-31
Total revenue: 9508372
Gross profit: 3485107
Operating income: -7962059
Net income: -11242404
Capital expenditures: 42920
Operating cash flow: -5295714
Depreciation & amortization: 538759
Net tangible assets: 30427799
Owner earnings: -10746565
Return on net tangible assets (%): -35.31824631811193
Buffett classification: The Gruesome
Stock price: 5.14
Shares outstanding: 25338799
Book value: 37490801
P/B ratio: 3.473956901054208
Market cap (USD): 130241426.85999998
Debt to equity: 0.12326181027713971
Current ratio: 18.449224786261894
Quick ratio: 13.507468216855372
COGS to revenue (%): 63.3469641280337
R&D to revenue (%): 37.7635098837109
SG&A to revenue (%): 82.6268787127807
Free cash flow (dilution-adjusted): -5856415
Buyback yield (%): 0
Retained earnings: -21012127
Inventory turnover: 0.7937083034865757
Receivables turnover: 7.565992560027055
Capitalized R&D asset: 5497693.0600000005
ROCI (R&D-adjusted, %): -14.179511832688538
Rosenberg metric: -1.618604561787821
FCF margin (%): -61.59219475216157
Revenue growth (%): -38.988578259134016
Rule of 40 score: -100.58077301129558
Financial ratios for AMPG — quarterly report dated 2024-12-31
Capital expenditures: 16489
Buffett classification: The Gruesome
Stock price: 5.14
Shares outstanding: 25338799
Market cap (USD): 130241426.85999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMPG — quarterly report dated 2025-03-31
Total revenue: 3599099
Gross profit: 1187870
Operating income: -1890018
Net income: -1840521
Capital expenditures: 361045
Operating cash flow: -2008947
Depreciation & amortization: 122060
Net tangible assets: 28739597
Owner earnings: -2079506
Return on net tangible assets (%): -7.235682532361187
Buffett classification: The Gruesome
Stock price: 1.55
Shares outstanding: 25338799
Book value: 35775366
P/B ratio: 1.0978263213295987
Market cap (USD): 39275138.45
Debt to equity: 0.1260018416024032
Current ratio: 12.103436571760254
Quick ratio: 8.878017703045428
COGS to revenue (%): 66.99535078084821
R&D to revenue (%): 20.551615834963137
SG&A to revenue (%): 64.96667638206117
Free cash flow (dilution-adjusted): -2495078
Buyback yield (%): 0
Retained earnings: -22852648
Inventory turnover: 0.33741981617894007
Receivables turnover: 1.6185226024803772
Capitalized R&D asset: 739673
ROCI (R&D-adjusted, %): -3.4417356866524718
FCF margin (%): -69.32507274737372
Rule of 40 score: -69.32507274737372
Financial ratios for AMPG — quarterly report dated 2025-06-30
Total revenue: 11025927
Gross profit: 862879
Operating income: -1925059
Net income: -1771625
Capital expenditures: 126447
Operating cash flow: -2251290
Depreciation & amortization: 256158
Net tangible assets: 20718031
Owner earnings: -1641914
Return on net tangible assets (%): -7.925048475890398
Buffett classification: The Gruesome
Stock price: 2.12
Shares outstanding: 25338799
Book value: 35812534
P/B ratio: 1.4999847226672092
Market cap (USD): 53718253.88
Debt to equity: 0.12333067523230833
Current ratio: 2.8233267963571165
Quick ratio: 1.9371777972928232
COGS to revenue (%): 92.17409112177144
R&D to revenue (%): 5.974962468008359
SG&A to revenue (%): 19.31033100436816
Free cash flow (dilution-adjusted): -2476163
Buyback yield (%): 0
Retained earnings: -24624273
Inventory turnover: 1.293721185625009
Receivables turnover: 2.054973801985767
Capitalized R&D asset: 1154375.9100000001
ROCI (R&D-adjusted, %): -4.232321482414044
Rosenberg metric: -0.43937118158970245
FCF margin (%): -22.457640069628614
Revenue growth (%): 206.35242320369628
Rule of 40 score: 183.89478313406767
Financial ratios for AMPG — quarterly report dated 2025-09-30
Total revenue: 6093832
Gross profit: 2959643
Operating income: -221256
Net income: -188373
Capital expenditures: 442636
Operating cash flow: -999351
Depreciation & amortization: 381094
Net tangible assets: 17556694
Owner earnings: -249915
Return on net tangible assets (%): -1.423474146100627
Buffett classification: The Gruesome
Stock price: 3.89
Shares outstanding: 25338799
Book value: 35818615
P/B ratio: 2.7518631892941703
Market cap (USD): 98567928.11
Debt to equity: 0.12000503090362372
Current ratio: 2.847586793198893
Quick ratio: 1.6777066034005537
COGS to revenue (%): 51.432153036053506
R&D to revenue (%): 11.475849678822783
SG&A to revenue (%): 40.7228161196436
Free cash flow (dilution-adjusted): -6274201
Buyback yield (%): 0
Retained earnings: -24812646
Inventory turnover: 0.35311300365563714
Receivables turnover: 1.7478139533549688
Capitalized R&D asset: 1384803.74
ROCI (R&D-adjusted, %): -0.5390216273204216
Rosenberg metric: 3.182726037690025
FCF margin (%): -102.95986170934808
Revenue growth (%): -44.731794433248105
Rule of 40 score: -147.69165614259617
Financial ratios for AMPG — annual report dated 2025-12-31
Total revenue: 25195930
Gross profit: 6030013
Operating income: -7319904
Net income: -7007155
Capital expenditures: 1015710
Operating cash flow: -8683707
Depreciation & amortization: 1292556
Net tangible assets: 15020722
Owner earnings: -6730309
Return on net tangible assets (%): -44.806827527997655
Buffett classification: The Gruesome
Stock price: 2.99
Shares outstanding: 25338799
Book value: 32862561
P/B ratio: 2.3054505402059204
Market cap (USD): 75763009.01
Debt to equity: 0.12715366279578758
Current ratio: 1.6815954863605294
Quick ratio: 1.083819278614585
COGS to revenue (%): 76.06751169732571
R&D to revenue (%): 10.66511932681191
SG&A to revenue (%): 42.31929918840066
Free cash flow (dilution-adjusted): -14983605
Buyback yield (%): 0
Retained earnings: -28019282
Inventory turnover: 2.151418128116685
Receivables turnover: 7.521828768358317
Capitalized R&D asset: 5865750.5
ROCI (R&D-adjusted, %): -17.685154634913953
Rosenberg metric: 0.7087502558696854
FCF margin (%): -59.468354611240784
Revenue growth (%): 164.98679269174576
Rule of 40 score: 105.51843808050498
Financial ratios for AMPG — quarterly report dated 2025-12-31
Total revenue: 4477072
Gross profit: 1019621
Operating income: -3283571
Net income: -3206636
Capital expenditures: 85582
Operating cash flow: -3424119
Depreciation & amortization: 533244
Net tangible assets: 15020722
Owner earnings: -2758974
Return on net tangible assets (%): -18.36778551656838
Buffett classification: The Gruesome
Stock price: 2.99
Shares outstanding: 25338799
Book value: 32862561
P/B ratio: 2.3054505402059204
Market cap (USD): 75763009.01
Debt to equity: 0.12715366279578758
Current ratio: 1.6815954863605294
Quick ratio: 1.083819278614585
COGS to revenue (%): 77.22571805858828
R&D to revenue (%): 13.164608476254122
SG&A to revenue (%): 82.95160319065675
Free cash flow (dilution-adjusted): -3738163
Buyback yield (%): 0
Retained earnings: -28019282
Inventory turnover: 0.38810680221954214
Receivables turnover: 1.336555902783168
Capitalized R&D asset: 1275335.08
ROCI (R&D-adjusted, %): -8.832742549735972
Rosenberg metric: -2.774158860262627
FCF margin (%): -83.4957088025388
Revenue growth (%): -26.53108914062613
Rule of 40 score: -110.02679794316492
Financial ratios for ATMU — annual report dated 2023-12-31
Total revenue: 1628100000
Gross profit: 432700000
Operating income: 214800000
Net income: 171300000
Capital expenditures: 45800000
Operating cash flow: 189000000
Depreciation & amortization: 21500000
Net tangible assets: -4000000
Owner earnings: 147000000
Return on net tangible assets (%): -3675
Capex to operating income (%): 21.32216014897579
Buffett classification: The Great
Stock price: 23.26
P/E ratio: 11.089904700992411
Shares outstanding: 81672428
Book value: 80700000
P/B ratio: 23.540280982403967
Market cap (USD): 1899700675.2800002
Debt to equity: 7.755885997521685
Current ratio: 1.848
Quick ratio: 1.1813333333333333
Effective tax rate (%): 24.337455830388695
Interest coverage ratio: 8.325581395348838
COGS to revenue (%): 73.42300841471653
R&D to revenue (%): 2.610404766291997
SG&A to revenue (%): 10.730299121675573
Free cash flow (dilution-adjusted): 136000000
Buyback yield (%): 0
Retained earnings: 87200000
Inventory turnover: 4.7816
Receivables turnover: 6.596839546191248
Capitalized R&D asset: 68362000
ROCI (R&D-adjusted, %): 29.4472962454271
Rosenberg metric: 1.9041450777202074
FCF margin (%): 8.353295252134389
Revenue growth (%): 4.225081620894949
Rule of 40 score: 12.578376873029338
Financial ratios for ATMU — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 37.22
Shares outstanding: 81672428
Market cap (USD): 3039847770.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATMU — annual report dated 2024-12-31
Total revenue: 1669600000
Gross profit: 462100000
Operating income: 231900000
Net income: 185600000
Capital expenditures: 48600000
Operating cash flow: 105400000
Depreciation & amortization: 24800000
Net tangible assets: 142700000
Owner earnings: 161800000
Return on net tangible assets (%): 113.38472319551506
Capex to operating income (%): 20.95730918499353
Buffett classification: The Great
Stock price: 38.9
P/E ratio: 17.11776642887931
Shares outstanding: 81672428
Book value: 227400000
P/B ratio: 13.97122888830255
Market cap (USD): 3177057449.2
Debt to equity: 2.777484608619173
Current ratio: 2.1890403015366773
Quick ratio: 1.4160626268483618
Effective tax rate (%): 20.954003407155025
Interest coverage ratio: 5.711822660098522
COGS to revenue (%): 72.32271202683278
R&D to revenue (%): 2.4317201724964064
SG&A to revenue (%): 11.236224245328222
Free cash flow (dilution-adjusted): 44900000
Buyback yield (%): 0.6295133254526483
Retained earnings: 264500000
Inventory turnover: 4.529257314328582
Receivables turnover: 6.568056648308419
Capitalized R&D asset: 81813000
ROCI (R&D-adjusted, %): 25.014029498435995
Rosenberg metric: 0.691764705882353
FCF margin (%): 2.689266890273119
Revenue growth (%): 2.5489834776733615
Rule of 40 score: 5.238250367946481
Financial ratios for ATMU — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 38.9
Shares outstanding: 81672428
Market cap (USD): 3177057449.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATMU — quarterly report dated 2025-03-31
Total revenue: 415900000
Gross profit: 110500000
Operating income: 55700000
Net income: 44700000
Capital expenditures: 12400000
Operating cash flow: 28700000
Depreciation & amortization: 7200000
Net tangible assets: 180600000
Owner earnings: 39500000
Return on net tangible assets (%): 21.87153931339978
Capex to operating income (%): 22.262118491921004
Buffett classification: The Great
Stock price: 36.52
P/E ratio: 16.681639097091725
Shares outstanding: 81672428
Book value: 265300000
P/B ratio: 11.242657634979269
Market cap (USD): 2982677070.5600004
Debt to equity: 2.3731624575951753
Current ratio: 2.226833428084139
Quick ratio: 1.4570778851620239
Effective tax rate (%): 21.30281690140845
Interest coverage ratio: 6.630952380952381
COGS to revenue (%): 73.57537869680212
R&D to revenue (%): 2.1880259677807166
SG&A to revenue (%): 11.036306804520317
Free cash flow (dilution-adjusted): 14000000
Buyback yield (%): 0.3352692820387187
Retained earnings: 305100000
Inventory turnover: 1.1299852289512555
Receivables turnover: 1.4727337110481586
Capitalized R&D asset: 9100000
ROCI (R&D-adjusted, %): 6.976131315412997
FCF margin (%): 3.3661937965857174
Rule of 40 score: 3.3661937965857174
Financial ratios for ATMU — quarterly report dated 2025-06-30
Total revenue: 453500000
Gross profit: 131000000
Operating income: 74200000
Net income: 59900000
Capital expenditures: 12000000
Operating cash flow: 44400000
Depreciation & amortization: 7400000
Net tangible assets: 231600000
Owner earnings: 55300000
Return on net tangible assets (%): 23.877374784110536
Capex to operating income (%): 16.172506738544474
Buffett classification: The Great
Stock price: 36.26
P/E ratio: 28.31206729713193
Shares outstanding: 81672428
Book value: 316300000
P/B ratio: 9.362763955991147
Market cap (USD): 2961442239.2799997
Debt to equity: 1.9734429339234905
Current ratio: 2.1459012283780394
Quick ratio: 1.431436450238155
Effective tax rate (%): 21.903520208604952
Interest coverage ratio: 8.729411764705882
COGS to revenue (%): 71.1135611907387
R&D to revenue (%): 2.3594266813671445
SG&A to revenue (%): 10.165380374862183
Free cash flow (dilution-adjusted): 29400000
Buyback yield (%): 0.6787233508524148
Retained earnings: 360800000
Inventory turnover: 1.131578947368421
Receivables turnover: 1.3643200962695547
Capitalized R&D asset: 16797000
ROCI (R&D-adjusted, %): 8.4022161247434
Rosenberg metric: 2.2527472527472527
FCF margin (%): 6.482910694597574
Revenue growth (%): 9.04063476797307
Rule of 40 score: 15.523545462570645
Financial ratios for ATMU — quarterly report dated 2025-09-30
Total revenue: 447700000
Gross profit: 129400000
Operating income: 73500000
Net income: 54800000
Capital expenditures: 13200000
Operating cash flow: 82100000
Depreciation & amortization: 7600000
Net tangible assets: 252000000
Owner earnings: 49200000
Return on net tangible assets (%): 19.523809523809526
Capex to operating income (%): 17.959183673469386
Buffett classification: The Great
Stock price: 44.95
P/E ratio: 23.031214796737768
Shares outstanding: 81672428
Book value: 336700000
P/B ratio: 10.90340255004455
Market cap (USD): 3671175638.6000004
Debt to equity: 1.836055836055836
Current ratio: 2.1418181818181816
Quick ratio: 1.4077575757575758
Effective tax rate (%): 23.570432357043238
Interest coverage ratio: 8.647058823529411
COGS to revenue (%): 71.096716551262
R&D to revenue (%): 2.233638597274961
SG&A to revenue (%): 10.25240116149207
Free cash flow (dilution-adjusted): 65600000
Buyback yield (%): 0.8090051504952258
Retained earnings: 411200000
Inventory turnover: 1.0511889035667108
Receivables turnover: 1.3834981458590854
Capitalized R&D asset: 20172000
ROCI (R&D-adjusted, %): 7.770262182095232
Rosenberg metric: -0.14953271028037382
FCF margin (%): 14.652669198123744
Revenue growth (%): -1.278941565600882
Rule of 40 score: 13.373727632522863
Financial ratios for ATMU — quarterly report dated 2025-12-31
Total revenue: 446600000
Gross profit: 127400000
Operating income: 61800000
Net income: 48000000
Capital expenditures: 16300000
Operating cash flow: 47500000
Depreciation & amortization: 7800000
Net tangible assets: 293800000
Owner earnings: 39500000
Return on net tangible assets (%): 13.444520081688225
Capex to operating income (%): 26.375404530744333
Buffett classification: The Good
Stock price: 51.81
P/E ratio: 20.402355326325942
Shares outstanding: 81672428
Book value: 378500000
P/B ratio: 11.179520461505946
Market cap (USD): 4231448494.6800003
Debt to equity: 1.6163804491413474
Current ratio: 2.42368278109723
Quick ratio: 1.6569799022270506
Effective tax rate (%): 21.311475409836063
Interest coverage ratio: 7.725
COGS to revenue (%): 71.47335423197492
R&D to revenue (%): 2.440662785490372
SG&A to revenue (%): 10.38961038961039
Free cash flow (dilution-adjusted): 27400000
Buyback yield (%): 0.021269312414685597
Retained earnings: 454600000
Inventory turnover: 1.130712008501594
Receivables turnover: 1.395189003436426
Capitalized R&D asset: 21131000
ROCI (R&D-adjusted, %): 6.19417561500857
Rosenberg metric: -0.2
FCF margin (%): 6.135244066278549
Revenue growth (%): -0.2457002457002457
Rule of 40 score: 5.889543820578304
Financial ratios for ATMU — annual report dated 2025-12-31
Total revenue: 1764300000
Gross profit: 498300000
Operating income: 265200000
Net income: 207400000
Capital expenditures: 53900000
Operating cash flow: 202700000
Depreciation & amortization: 30000000
Net tangible assets: 293800000
Owner earnings: 183500000
Return on net tangible assets (%): 62.45745405037441
Capex to operating income (%): 20.324283559577676
Buffett classification: The Great
Stock price: 51.81
P/E ratio: 20.402355326325942
Shares outstanding: 81672428
Book value: 378500000
P/B ratio: 11.179520461505946
Market cap (USD): 4231448494.6800003
Debt to equity: 1.6163804491413474
Current ratio: 2.42368278109723
Quick ratio: 1.6569799022270506
Effective tax rate (%): 22.088655146506387
Interest coverage ratio: 7.940119760479042
COGS to revenue (%): 71.75650399591906
R&D to revenue (%): 2.306863912033101
SG&A to revenue (%): 10.446069262597064
Free cash flow (dilution-adjusted): 136400000
Buyback yield (%): 1.434496959523795
Retained earnings: 454600000
Inventory turnover: 4.484590860786398
Receivables turnover: 5.511715089034677
Capitalized R&D asset: 81927000
ROCI (R&D-adjusted, %): 24.861576541494472
Rosenberg metric: 0.8916256157635468
FCF margin (%): 7.731111488975798
Revenue growth (%): 5.672017249640633
Rule of 40 score: 13.40312873861643
Financial ratios for ATNM — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.01
Shares outstanding: 31374994
Market cap (USD): 188563713.94
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATNM — annual report dated 2022-12-31
Total revenue: 85840.49
Operating income: -34104000
Net income: -33017000
Capital expenditures: 366000
Operating cash flow: 8644000
Depreciation & amortization: 699000
Net tangible assets: 66481000
Owner earnings: -32684000
Return on net tangible assets (%): -49.162918728659314
Buffett classification: The Gruesome
Stock price: 10.65
Shares outstanding: 31374994
Book value: 66481000
P/B ratio: 5.026153127961372
Market cap (USD): 334143686.1
Debt to equity: 0.0388231223958725
Current ratio: 10.438652615732028
Quick ratio: 10.438652615732028
COGS to revenue (%): 0
R&D to revenue (%): 26951.150907922358
SG&A to revenue (%): 13978.251988076954
Free cash flow (dilution-adjusted): 5483000
Buyback yield (%): 0
Retained earnings: -288765000
Capitalized R&D asset: 23135000
ROCI (R&D-adjusted, %): -14.744131103376246
FCF margin (%): 6387.428589934656
Rule of 40 score: 6387.428589934656
Financial ratios for ATNM — annual report dated 2023-12-31
Total revenue: 81000
Operating income: -51920000
Net income: -48818000
Capital expenditures: 153000
Operating cash flow: -47335000
Depreciation & amortization: 790000
Net tangible assets: 36379000
Owner earnings: -48181000
Return on net tangible assets (%): -132.44179334231288
Buffett classification: The Gruesome
Stock price: 5.08
Shares outstanding: 31374994
Book value: 36379000
P/B ratio: 4.3812355897633255
Market cap (USD): 159384969.52
Debt to equity: 0.05808295994942137
Current ratio: 9.213915705203673
Quick ratio: 9.213915705203673
COGS to revenue (%): 0
R&D to revenue (%): 47740.74074074074
SG&A to revenue (%): 16458.024691358027
Free cash flow (dilution-adjusted): -51330000
Buyback yield (%): 0
Retained earnings: -337583000
Capitalized R&D asset: 54170450
ROCI (R&D-adjusted, %): -26.629389978376327
FCF margin (%): -63370.37037037037
Revenue growth (%): -5.6389356584520955
Rule of 40 score: -63376.00930602883
Financial ratios for ATNM — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.88
Shares outstanding: 31374994
Market cap (USD): 58984988.72
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATNM — annual report dated 2024-12-31
Total revenue: 0
Operating income: -42121000
Net income: -38243000
Capital expenditures: 11000
Operating cash flow: -33072000
Depreciation & amortization: 811000
Net tangible assets: 32758000
Owner earnings: -37443000
Return on net tangible assets (%): -114.30184992978813
Buffett classification: The Gruesome
Stock price: 1.26
Shares outstanding: 31374994
Book value: 32758000
P/B ratio: 1.2068042139324746
Market cap (USD): 39532492.44
Debt to equity: 0.04801880456682337
Current ratio: 9.14408443789887
Quick ratio: 9.14408443789887
Free cash flow (dilution-adjusted): -38375000
Buyback yield (%): 0
Retained earnings: -375826000
Capitalized R&D asset: 63588450
ROCI (R&D-adjusted, %): -32.259969847741296
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for ATNM — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.26
Shares outstanding: 31374994
Market cap (USD): 39532492.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATNM — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -16638000
Net income: -15938000
Capital expenditures: 0
Operating cash flow: -7574000
Depreciation & amortization: 205000
Net tangible assets: 25694000
Owner earnings: -15733000
Return on net tangible assets (%): -61.23219428660388
Buffett classification: The Gruesome
Stock price: 1.61
Shares outstanding: 31374994
Book value: 25694000
P/B ratio: 1.9659741706234921
Market cap (USD): 50513740.34
Debt to equity: 0.05577177551179264
Current ratio: 9.346835443037975
Quick ratio: 9.346835443037975
Free cash flow (dilution-adjusted): -16448000
Buyback yield (%): 0
Retained earnings: -391764000
Capitalized R&D asset: 7700000
ROCI (R&D-adjusted, %): -16.61635637977767
Rule of 40 score: 0